Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli

[1] Poorter RL(1996)Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy Eur J Cancer 32A 2262-6

[2] Lauw FN(1997)Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device Eur J Cancer 33 1190-4

[3] Bemelman WA(1998)Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems World J Surg 22 12-6

[4] Bakker PJ(2012)Update on totally implantable venous access devices Surg Oncol 21 207-15

[5] Taat CW(2010)Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study J Korean Med Sci 25 1748-53

[6] Veenhof CH(2006)Protocol for the implantation of a venous access device (Port-A-Cath System). The complications and solutions found in 560 cases Clin Transl Oncol 8 735-41

[7] Biffi R(2004)Implantable venous port-related infections in cancer patients Support Care Cancer 12 197-201

[8] Corrado F(2014)Incidence and risk factors of infectious complications related to implantable venous-access ports Korean J Radiol 15 494-500

[9] de Braud F(2014)Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center Medicine (Baltimore) 93 143-9

[10] de Lucia F(2014)A case–control study to identify risk factors for totally implantable central venous port-related bloodstream infection Cancer Res Treat 46 250-60

[1] Poorter RL(1996)Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy Eur J Cancer 32A 2262-6

[2] Lauw FN(1997)Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device Eur J Cancer 33 1190-4

[3] Bemelman WA(1998)Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems World J Surg 22 12-6

[4] Bakker PJ(2012)Update on totally implantable venous access devices Surg Oncol 21 207-15

[5] Taat CW(2010)Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study J Korean Med Sci 25 1748-53

[6] Veenhof CH(2006)Protocol for the implantation of a venous access device (Port-A-Cath System). The complications and solutions found in 560 cases Clin Transl Oncol 8 735-41

[7] Biffi R(2004)Implantable venous port-related infections in cancer patients Support Care Cancer 12 197-201

[8] Corrado F(2014)Incidence and risk factors of infectious complications related to implantable venous-access ports Korean J Radiol 15 494-500

[9] de Braud F(2014)Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center Medicine (Baltimore) 93 143-9

[10] de Lucia F(2014)A case–control study to identify risk factors for totally implantable central venous port-related bloodstream infection Cancer Res Treat 46 250-60